147 related articles for article (PubMed ID: 36842094)
1. Inflammation in the peripheral blood system of Crohn's Disease.
Li D; Gu W; Xu H; Zhang Z; Zhao C; He C; Zhu X; Li Y
Clin Exp Med; 2023 Oct; 23(6):2805-2812. PubMed ID: 36842094
[TBL] [Abstract][Full Text] [Related]
2. [The mechanism by which hsa_circRNA_103124 highly expressed in peripheral blood of patients with active Crohn's disease regulates macrophage differentiation, pyroptosis and inflammation].
Yin J; Hu T; Xu LJ; Zhang LP; Ye YL; Pang Z
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(43):3478-3486. PubMed ID: 37981775
[No Abstract] [Full Text] [Related]
3. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
[TBL] [Abstract][Full Text] [Related]
4. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K
Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn's disease.
Duarte-Silva M; Parra RS; Feitosa MR; Nardini V; Maruyama SR; da Rocha JJR; Feres O; de Barros Cardoso CR
Clin Exp Immunol; 2024 Jun; 217(1):78-88. PubMed ID: 38517030
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
[TBL] [Abstract][Full Text] [Related]
7. LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.
Broekman MM; Roelofs HM; Hoentjen F; Wiegertjes R; Stoel N; Joosten LA; de Jong DJ; Wanten GJ
PLoS One; 2015; 10(7):e0133932. PubMed ID: 26208333
[TBL] [Abstract][Full Text] [Related]
8. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
[TBL] [Abstract][Full Text] [Related]
10. MALT1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.
Dong X; Chen X; Ren Y
J Clin Lab Anal; 2022 Oct; 36(10):e24650. PubMed ID: 36036788
[TBL] [Abstract][Full Text] [Related]
11. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
12. IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease.
Seidelin JB; Jensen S; Hansen M; de Carvalho Bronze MR; Cuchet-Lourenҫo D; Nejentsev S; LaCasse EC; Nielsen OH
Clin Exp Immunol; 2024 Feb; 215(3):291-301. PubMed ID: 37583360
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
[TBL] [Abstract][Full Text] [Related]
14. The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes.
Gren ST; Janciauskiene S; Sandeep S; Jonigk D; Kvist PH; Gerwien JG; Håkansson K; Grip O
J Leukoc Biol; 2016 Oct; 100(4):811-822. PubMed ID: 27190304
[TBL] [Abstract][Full Text] [Related]
15. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
16. An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients.
Bassolas-Molina H; Raymond E; Labadia M; Wahle J; Ferrer-Picón E; Panzenbeck M; Zheng J; Harcken C; Hughes R; Turner M; Smith D; Calderón-Gómez E; Esteller M; Carrasco A; Esteve M; Dotti I; Corraliza AM; Masamunt MC; Arajol C; Guardiola J; Ricart E; Nabozny G; Salas A
Front Immunol; 2018; 9():2307. PubMed ID: 30405600
[No Abstract] [Full Text] [Related]
17. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
Bauditz J; Wedel S; Lochs H
Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
[TBL] [Abstract][Full Text] [Related]
18. Increased proinflammatory cytokines in mesenteric fat in major surgery and Crohn's disease.
Seifarth C; Hering NA; Arndt M; Lehmann KS; Stroux A; Weixler B; Kreis ME
Surgery; 2021 Jun; 169(6):1328-1332. PubMed ID: 33431185
[TBL] [Abstract][Full Text] [Related]
19. Silibinin Downregulates the NF-κB Pathway and NLRP1/NLRP3 Inflammasomes in Monocytes from Pregnant Women with Preeclampsia.
Matias ML; Gomes VJ; Romao-Veiga M; Ribeiro VR; Nunes PR; Romagnoli GG; Peracoli JC; Peracoli MTS
Molecules; 2019 Apr; 24(8):. PubMed ID: 31010153
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-19 impairment in active Crohn's disease patients.
Cantó E; Garcia Planella E; Zamora-Atenza C; Nieto JC; Gordillo J; Ortiz MA; Metón I; Serrano E; Vegas E; García-Bosch O; Juárez C; Vidal S
PLoS One; 2014; 9(4):e93910. PubMed ID: 24718601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
